Drug class
5-nitroimidazole; hypoxic-cell radiosensitiser and antiprotozoal agent
Mechanism of action
Under low-oxygen conditions, nitroimidazole reduction produces reactive intermediates that mimic oxygen fixation of radiation-induced DNA damage, increasing radiosensitivity of hypoxic tumour cells. It also produces DNA damage in susceptible protozoa and anaerobic organisms.
General use cases
- Used as a radiosensitiser with radiotherapy for selected head-and-neck squamous-cell carcinomas in countries where authorised
- Antiprotozoal and anaerobic antibacterial uses are country- and product-specific and should not be inferred from the radiosensitiser indication
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
